LPL Financial
ABEO icon

LPL Financial’s Abeona Therapeutics ABEO Stock Holding History

LPL Financial’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Buy
65,148
+2,275
+4% +$11.4K ﹤0.01% 5203
2025
Q4 		$331K Buy
62,873
+3,165
+5% +$15.9K ﹤0.01% 5067
2025
Q3 		$315K Buy
59,708
+710
+1% +$4.5K ﹤0.01% 5013
2025
Q2 		$335K Buy
58,998
+688
+1% +$3.92K ﹤0.01% 4700
2025
Q1 		$278K Buy
58,310
+7,550
+15% +$41.1K ﹤0.01% 4634
2024
Q4 		$283K Sell
50,760
-900
-2% -$5.54K ﹤0.01% 4578
2024
Q3 		$326K Buy
51,660
+675
+1% +$3.52K ﹤0.01% 4358
2024
Q2 		$216K Buy
50,985
+20,445
+67% +$104K ﹤0.01% 4503
2024
Q1 		$221K Buy
30,540
+1,200
+4% +$7.61K ﹤0.01% 4437
2023
Q4 		$147K Buy
29,340
+4,890
+20% +$21.5K ﹤0.01% 4473
2023
Q3 		$103K Buy
+24,450
New +$92.5K ﹤0.01% 4408

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial's ABEO Position: Q1 2026 in Review

LPL Financial increased its Abeona Therapeutics (ABEO) stake by 3.6% in Q1 2026, buying an estimated $11.4K and bringing the position to 65,148 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #5203.

LPL Financial first reported a position in ABEO in Q3 2023 and has held it in 11 quarters since. The position peaked at $335K in Q2 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • LPL Financial held 65,148 shares of Abeona Therapeutics worth $292K as of Q1 2026.
  • LPL Financial bought 2,275 Abeona Therapeutics shares in Q1 2026, an estimated $11.4K.
  • Abeona Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5203 holding.
  • LPL Financial first reported a position in Abeona Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • LPL Financial's Abeona Therapeutics position peaked at $335K in Q2 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.